|Awarded On||August 24, 2018|
|Title||HPV Vaccination in a Pediatric Minority-Based Community Oncology Network|
|Award Mechanism||Evidence-Based Prevention Programs and Services|
|Institution/Organization||The University of Texas Health Science Center at San Antonio|
|Principal Investigator/Program Director||Allison Grimes|
Human papillomavirus (HPV) is known to cause most cervical, anal, and oropharyngeal cancers, and a large proportion of vaginal, vulvar, and penile malignancies. Every year, nearly 31,000 new cases of HPV-related cancers are diagnosed in the United States alone. This incidence persists nearly a decade following the launch of the HPV vaccine in 2006, and in fact is rising with continued poor HPV vaccine uptake. In 2016, only 43% of females and 32% of males completed the 3-dose series and rates in Texas are even lower where HPV-related malignancies are highest among the state’s predominately Hispanic population. Thus, HPV vaccine initiatives targeting Texans are critical, beginning with ...